Answers are grounded in this paper and cite their sources.
These guidelines outline systemic therapy choices for patients with multiple myeloma, indicating new important options.
This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, recommendations highlight important updates specific to systemic therapy options for those with newly diagnosed or previously treated multiple myeloma. In addition, a persistent PSA level following radical prostatectomy for prostate cancer is associated with a worse prognosis, and outcomes show a reduction in treatment failure associated with dose‐escalated, hypofractionated radiation therapy for localized prostate cancer.
No takes yet. Share an insight, caveat, or question.
Mary Beth Nierengarten (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: